Hemoperfusion - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504246664

Publication Date:

April 7, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
The global market for Hemoperfusion was estimated to be worth US$ 501 million in 2023 and is forecast to a readjusted size of US$ 1626.3 million by 2030 with a CAGR of 18.1% during the forecast period 2024-2030
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemoperfusion by region & country, by Type, and by Application.
The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.
麻豆原创 Segmentation
By Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
Segment by Type:
Activated Carbon Adsorption
Resin Adsorption
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemoperfusion in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Hemoperfusion Product Introduction
1.2 Global Hemoperfusion 麻豆原创 Size Forecast
1.2.1 Global Hemoperfusion Sales Value (2019-2030)
1.2.2 Global Hemoperfusion Sales Volume (2019-2030)
1.2.3 Global Hemoperfusion Sales Price (2019-2030)
1.3 Hemoperfusion 麻豆原创 Trends & Drivers
1.3.1 Hemoperfusion Industry Trends
1.3.2 Hemoperfusion 麻豆原创 Drivers & Opportunity
1.3.3 Hemoperfusion 麻豆原创 Challenges
1.3.4 Hemoperfusion 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hemoperfusion Players Revenue Ranking (2023)
2.2 Global Hemoperfusion Revenue by Company (2019-2024)
2.3 Global Hemoperfusion Players Sales Volume Ranking (2023)
2.4 Global Hemoperfusion Sales Volume by Company Players (2019-2024)
2.5 Global Hemoperfusion Average Price by Company (2019-2024)
2.6 Key Manufacturers Hemoperfusion Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hemoperfusion Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hemoperfusion
2.9 Hemoperfusion 麻豆原创 Competitive Analysis
2.9.1 Hemoperfusion 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hemoperfusion Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Activated Carbon Adsorption
3.1.2 Resin Adsorption
3.2 Global Hemoperfusion Sales Value by Type
3.2.1 Global Hemoperfusion Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hemoperfusion Sales Value, by Type (2019-2030)
3.2.3 Global Hemoperfusion Sales Value, by Type (%) (2019-2030)
3.3 Global Hemoperfusion Sales Volume by Type
3.3.1 Global Hemoperfusion Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hemoperfusion Sales Volume, by Type (2019-2030)
3.3.3 Global Hemoperfusion Sales Volume, by Type (%) (2019-2030)
3.4 Global Hemoperfusion Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hepatic Encephalopathy
4.1.2 Certain Autoimmune Diseases
4.1.3 Drug Overdose
4.1.4 Specific Intoxications
4.1.5 Others
4.2 Global Hemoperfusion Sales Value by Application
4.2.1 Global Hemoperfusion Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hemoperfusion Sales Value, by Application (2019-2030)
4.2.3 Global Hemoperfusion Sales Value, by Application (%) (2019-2030)
4.3 Global Hemoperfusion Sales Volume by Application
4.3.1 Global Hemoperfusion Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hemoperfusion Sales Volume, by Application (2019-2030)
4.3.3 Global Hemoperfusion Sales Volume, by Application (%) (2019-2030)
4.4 Global Hemoperfusion Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hemoperfusion Sales Value by Region
5.1.1 Global Hemoperfusion Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hemoperfusion Sales Value by Region (2019-2024)
5.1.3 Global Hemoperfusion Sales Value by Region (2025-2030)
5.1.4 Global Hemoperfusion Sales Value by Region (%), (2019-2030)
5.2 Global Hemoperfusion Sales Volume by Region
5.2.1 Global Hemoperfusion Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hemoperfusion Sales Volume by Region (2019-2024)
5.2.3 Global Hemoperfusion Sales Volume by Region (2025-2030)
5.2.4 Global Hemoperfusion Sales Volume by Region (%), (2019-2030)
5.3 Global Hemoperfusion Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hemoperfusion Sales Value, 2019-2030
5.4.2 North America Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hemoperfusion Sales Value, 2019-2030
5.5.2 Europe Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hemoperfusion Sales Value, 2019-2030
5.6.2 Asia Pacific Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hemoperfusion Sales Value, 2019-2030
5.7.2 South America Hemoperfusion Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hemoperfusion Sales Value, 2019-2030
5.8.2 Middle East & Africa Hemoperfusion Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hemoperfusion Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hemoperfusion Sales Value
6.2.1 Key Countries/Regions Hemoperfusion Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hemoperfusion Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hemoperfusion Sales Value, 2019-2030
6.3.2 United States Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hemoperfusion Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hemoperfusion Sales Value, 2019-2030
6.4.2 Europe Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hemoperfusion Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hemoperfusion Sales Value, 2019-2030
6.5.2 China Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hemoperfusion Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hemoperfusion Sales Value, 2019-2030
6.6.2 Japan Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hemoperfusion Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hemoperfusion Sales Value, 2019-2030
6.7.2 South Korea Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hemoperfusion Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hemoperfusion Sales Value, 2019-2030
6.8.2 Southeast Asia Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hemoperfusion Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hemoperfusion Sales Value, 2019-2030
6.9.2 India Hemoperfusion Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hemoperfusion Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Jafron Biomedical
7.1.1 Jafron Biomedical Company Information
7.1.2 Jafron Biomedical Introduction and Business Overview
7.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Jafron Biomedical Hemoperfusion Product Offerings
7.1.5 Jafron Biomedical Recent Development
7.2 Baxter (Gambro)
7.2.1 Baxter (Gambro) Company Information
7.2.2 Baxter (Gambro) Introduction and Business Overview
7.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Baxter (Gambro) Hemoperfusion Product Offerings
7.2.5 Baxter (Gambro) Recent Development
7.3 Asahi-Kasei
7.3.1 Asahi-Kasei Company Information
7.3.2 Asahi-Kasei Introduction and Business Overview
7.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Asahi-Kasei Hemoperfusion Product Offerings
7.3.5 Asahi-Kasei Recent Development
7.4 Biosun Medical
7.4.1 Biosun Medical Company Information
7.4.2 Biosun Medical Introduction and Business Overview
7.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biosun Medical Hemoperfusion Product Offerings
7.4.5 Biosun Medical Recent Development
7.5 Kaneka
7.5.1 Kaneka Company Information
7.5.2 Kaneka Introduction and Business Overview
7.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Kaneka Hemoperfusion Product Offerings
7.5.5 Kaneka Recent Development
7.6 Toray Medical
7.6.1 Toray Medical Company Information
7.6.2 Toray Medical Introduction and Business Overview
7.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Toray Medical Hemoperfusion Product Offerings
7.6.5 Toray Medical Recent Development
7.7 Cytosorbents
7.7.1 Cytosorbents Company Information
7.7.2 Cytosorbents Introduction and Business Overview
7.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cytosorbents Hemoperfusion Product Offerings
7.7.5 Cytosorbents Recent Development
7.8 Aier
7.8.1 Aier Company Information
7.8.2 Aier Introduction and Business Overview
7.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Aier Hemoperfusion Product Offerings
7.8.5 Aier Recent Development
7.9 Zibo Kangbei
7.9.1 Zibo Kangbei Company Information
7.9.2 Zibo Kangbei Introduction and Business Overview
7.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zibo Kangbei Hemoperfusion Product Offerings
7.9.5 Zibo Kangbei Recent Development
8 Industry Chain Analysis
8.1 Hemoperfusion Industrial Chain
8.2 Hemoperfusion Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hemoperfusion Sales Model
8.5.2 Sales Channel
8.5.3 Hemoperfusion Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.